Business
CanadaBis Capital Inc. Secures Cannabis Sales License for Stigma Grow, Remains Focused on Becoming a Canadian Leader in Concentrates
CanadaBis Capital Inc. Secures Cannabis Sales License for Stigma Grow, Remains Focused on ...
About this update from Canadabis Capital, Inc.
[{"type":"text","content":"\n\n\n\nCanadaBis Capital Inc. Secures Cannabis Sales License for Stigma Grow, Remains Focused on Becoming a Canadian Leader in Concentrates\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nRED DEER, AB, March 10, 2020\n\n\n\nRED DEER, AB, March 10, 2020 /CNW/ - CanadaBis Capital Inc. (TSX-V: CANB) (\"CanadaBis\" or \"the Company\") a holder of a federal licence to cultivate and process under the Cannabis Act, is pleased to announce that on March 6th, 2020, its subsidiary 1998643 AB LTD. (\"Stigma Grow\") secured its licence from Health Canada to sell cannabis cultivated at its 66,000 square foot cultivation facility in Red Deer, Alberta. \n\n \n \n \n \n \n \n\n \nSecuring their sales licence for dry flower represents a huge milestone along the way to achieving their vision as a well-positioned, multi-pillared cannabis company, and will act as the cornerstone for several brands within the CanadaBis' family of brands as they continue to grow in multiple areas; keenly seeking out new partnerships and opportunities to provide value to their industry and stakeholders.\n\"We are thrilled to secure approval to begin selling our high-quality cannabis,\" said Travis McIntyre, CEO of CanadaBis Capital Inc. \"We are now perfectly positioned to grow and sell dry flower that will be among the highest potency available today, which is important when you consider what's lacking in the current market and what's needed to ensure the future of legal cannabis remains bright\" said President & CEO, Travis McIntyre. \nThe Company anticipates a shift in consumer behaviour from a focus on dry flower to a focus on concentrates in 2020 and beyond. To prepare for this demand, the Company has spent six months perfecting their systems and constructing a CIDI Lab to house hydrocarbon extraction processing — positioning them to bring difficult-to-produce products to market on a mass scale.\n\"We're just getting started! Stigma Grow intends to leverage our own top-quality flower, state-of-the-art technology, and the insight provided by our skilled and experienced staff, ...